Prognostic factors after pulmonary metastasectomy for colorectal cancer and rationale for determining surgical indications: A retrospective analysis

Annals of Surgery

Volumn 257, Issue 6, 2013, Pages 1059-1064

  Iida, Tomohiko ^a   Nomori, Hiroaki ^b   Shiba, Mitsutoshi ^a   Nakajima, Jun ^c   Okumura, Sakae ^d   Horio, Hirotoshi ^e   Matsuguma, Haruhisa ^f   Ikeda, Norihiko ^g   Yoshino, Ichiro ^h   Ozeki, Yuichi ⁱ   Takagi, Keigo ^j   Goya, Tomoyuki ^k   Kawamura, Masafumi ^l   Hamada, Chikuma ^m   Kobayashi, Koichi ^b  

^a KIMITSU CHUO HOSPITAL   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d CANCER INSTITUTE HOSPITAL   (Japan)

^e TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^f TOCHIGI CANCER CENTER   (Japan)

^g TOKYO MEDICAL UNIVERSITY   (Japan)

^h CHIBA UNIVERSITY   (Japan)

ⁱ NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^j TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^k KYORIN UNIVERSITY   (Japan)

^l TEIKYO UNIVERSITY   (Japan)

^m TOKYO UNIVERSITY OF SCIENCE   (Japan)

more..

Author keywords

Colorectal cancer; Prognostic factor; Pulmonary metastasectomy; Pulmonary metastasis; Surgical indication

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS RESECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL TIME; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84879070529     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31826eda3b     Document Type: Article

References (21)

1. Bendell J. Optimum chemotherapy for metastatic colorectal cancer. Lancet. 2006;368:2039-2041.
2. Douillard JY, Siena S, Cassidy J, et al. Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study. J Clin Oncol. 2010;28:4697-4705.
3. Pfannschmidt J, Hoffmann H, Dienemann H. Reported outcome factors for pulmonary resection in metastatic colorectal cancer. J Thorac Oncol. 2010;5:S172-S178.
4. Pfannschmidt J, Muley T, Hoffmann H, et al. Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: experiences in 167 patients. J Thorac Cardiovasc Surg. 2003;126:732-739.
5. Onaitis MW, Petersen RP, Haney JC, et al. Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastases. Ann Thorac Surg. 2009;87:1684-1688.
6. Borasio P, Gisabella M, Bilĺe A, et al. Role of surgical resection in colorectal lung metastases: analysis of 137 patients. Int J Colorectal Dis. 2011;26:183-190.
7. Iizasa T, Suzuki M, Yoshida S, et al. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer. Ann Thorac Surg. 2006;82:254-260.
8. Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg. 2007;84:324-338.
9. Vogelsang H, Haas S, Hierholzer C, et al. Factors influencing survival after resection of pulmonary metastases from colorectal cancer. Br J Surg. 2004;91:1066-1071.
10. Hwang MR, Park JW, Kim DY, et al. Early intrapulmonary recurrence after pulmonary metastasectomy related to colorectal cancer. Ann Thorac Surg. 2010;90:398-404.
11. Kanemitsu Y, Kato T, Hirai T, et al. Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer. Br J Surg. 2004;91:112-120.
12. Treasure T, Fallowfield L, Lees B. Pulmonary metastasectomy in colorectal cancer: the PulMiCC trial. J Thorac Oncol. 2010;5:S203-S206.
13. Thomford NR, Woolner LB, Clagett OT. The surgical treatment of metastatic tumors in the lungs. J Thorac Cardiovasc Surg. 1965;49:357-363.
14. NCCN Clinical Practice Guidelines in Oncology Version 2.2012: Colon cancer. Available at: http://www.nccn.org/professionals/physiciangls/pdf/colon. pdf. Accessed December 8, 2011.
15. Ewing J. Metastasis. Neoplastic Disease. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1928.
16. Zeidman I, McCutcheon M, Coman DR. Factors affecting the number of tumor metastases: experiments with a transplantable mouse tumor. Cancer Res. 1950;10:357-359.
17. Weiss L. Comments on hematogenous metastatic patterns in humans as revealed by autopsy. Clin Exp Metastasis. 1992;10:191-199.
18. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2002;2:563-572.
19. Headrick JR, Miller DL, Nagorney DM, et al. Surgical treatment of hepatic and pulmonary metastases from colon cancer. Ann Thorac Surg. 2001;71:975-979.
20. Chen F, Sakai H, Miyahara R, et al. Repeat resection of pulmonary metastasis is beneficial for patients with colorectal carcinoma. World J Surg. 2010;34:2373-2378.
21. Roth ES, Fetzer DT, Barron BJ, et al. Does colon cancer ever metastasize to bone first? A temporal analysis of colorectal cancer progression [published online ahead of print Aug. 7]. BMC Cancer. 2009.